# A Phase I Study of XH-S002 in Healthy Volunteers

> **NCT06204419** · PHASE1 · UNKNOWN · sponsor: **S-INFINITY Pharmaceuticals Co., Ltd** · enrollment: 86 (estimated)

## Conditions studied

- Healthy Adults

## Interventions

- **DRUG:** XH-S002 （A）
- **OTHER:** Placebo（B）

## Key facts

- **NCT ID:** NCT06204419
- **Lead sponsor:** S-INFINITY Pharmaceuticals Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-26
- **Primary completion:** 2024-07
- **Final completion:** 2024-10
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2024-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06204419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06204419, "A Phase I Study of XH-S002 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06204419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*